Published

17 Dec 25

Updated

04 Aug 26

Views

Not Invested

Devyser DiagnosticsDVYSR

Fair Value

SEK 97.58

Share price04 Aug

SEK 58.939.6% undervalued

1Y-61.15%

7D-1.17%

Transplant And Prenatal Testing Expansion Will Drive Strong Long Term Market Position

AnalystConsensusTarget

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published

17 Dec 25

Updated

04 Aug 26

Views

Not Invested

Shared on 04 Aug 26

Fair value Decreased 19%

DVYSR: Italian Tender And New Chimerism Assay Will Support Future Upside

Devyser rolls out a new transplant test designed to cut lab errors and speed up workflows, while also landing a multi-year hospital contract in Italy that adds more predictable demand. At the same time, expectations for what the market will pay for the business cools, which could reshape how investors weigh the upside from these wins.

2 views

Shared on 20 Jul 26

Fair value Decreased 23%

DVYSR: Italian Tender Wins Will Support Long-Term Genetic Diagnostics Momentum

Devyser wins a new multi-year deal in Italy and rolls out an updated transplant test designed to make tricky lab work simpler and less error-prone. But expectations cool as analysts dial back their outlook and lower what they think the company is worth.

5 views

Fair Value vs Share Price

SEK 97.58

vs SEK 58.939.6% undervalued

76.6k%

Revenue growth

26%

Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Devyser Diagnostics

Fair value estimate changes
Narrative and analyst updates
Key company announcements

Company analysis

Flawless balance sheet with reasonable growth potential.

Market capSEK 994.8m

PB2.6x

Estimated Growth18.7%

Dividend YieldN/A

Full analysis

CEO & management

Jan Wahlstrom

CEO

3.8yrs

CEO Tenure

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.